[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100499034":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":21,"responsibleParty":40,"collaborators":42,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":54,"maxAge":7,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":66,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Technical University of Munich","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Uta Behrends, Prof. Dr. med.","MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital","PRINCIPAL_INVESTIGATOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","+4989 30682632","uta.behrends@tum.de",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":7},"Daniela Schindler, Dr.","+4989 41406995",[22],{"facility":11,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Munich","Bavaria","80804","Germany","DE",{"type":30,"coordinates":31},"Point",[32,33],11.57549,48.13743,{"lat":33,"lon":32},[36],{"name":37,"role":15,"phone":38,"phoneExt":7,"email":39},"Uta Behrends, Prof.","+89 30682632","register.mcfc@mri.tum.de",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[43],{"name":44,"class":6},"Charite University, Berlin, Germany","100499034","multi-center-registry-for-mecfs-100499034",false,"NCT05778006","Multi-Center Registry for ME\u002FCFS","Multi-Center Registry for ME\u002FCFS, Including ME\u002FCFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)","MECFS-R","Inclusion Criteria:\n\n* ME\u002FCFS diagnosis (ICD-10 G93.3) based on internationally established criteria\n* Informed consent by patients and\u002For guardian(s)\n\nExclusion Criteria:\n\n* No ME\u002FCFS (ICD-10 G93.3)\n* No informed consent","ALL","0 Years",{"count":56,"type":57},650,"ESTIMATED","30 Years","OBSERVATIONAL","The ME\u002FCFS study (MECFS-R) aims to create a large-scale registry that provides data on epidemiology, phenotypes, and disease trajectories of and health care for ME\u002FCFS at any age in Germany, which can be used for future clinical trials.",[62,63,64,65],"ME\u002FCFS","CFS\u002FME","ME\u002FCFS Following EBV-associated Infectious Mononucleosis","ME\u002FCFS Following COVID-19",[62,63,67,68,69,70,71,72,73],"SARS-CoV-2","COVID-10","Post-COVID-19 condition","Chronic fatigue syndrome","Myalgic encephalomyelitis","Epstein-Barr virus","EBV","2025-01-08",{"date":76,"type":77},"2025-01-10","ACTUAL",{"date":79,"type":77},"2022-05-31",{"date":81,"type":57},"2052-05-31",{"name":5,"class":6},1]